319 reports of this reaction
2.3% of all AZELASTINE HYDROCHLORIDE reports
#8 most reported adverse reaction
COUGH is the #8 most commonly reported adverse reaction for AZELASTINE HYDROCHLORIDE, manufactured by Alembic Pharmaceuticals Limited. There are 319 FDA adverse event reports linking AZELASTINE HYDROCHLORIDE to COUGH. This represents approximately 2.3% of all 14,064 adverse event reports for this drug.
Patients taking AZELASTINE HYDROCHLORIDE who experience cough should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
COUGH is a less commonly reported adverse event for AZELASTINE HYDROCHLORIDE, but still significant enough to appear in the safety profile.
In addition to cough, the following adverse reactions have been reported for AZELASTINE HYDROCHLORIDE:
The following drugs have also been linked to cough in FDA adverse event reports:
COUGH has been reported as an adverse event in 319 FDA reports for AZELASTINE HYDROCHLORIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
COUGH accounts for approximately 2.3% of all adverse event reports for AZELASTINE HYDROCHLORIDE, making it a notable side effect.
If you experience cough while taking AZELASTINE HYDROCHLORIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.